Groupe la Francaise Decreases Stock Position in Agilent Technologies, Inc. $A

Posted by Brenda Bartman on Sep 8th, 2026

Groupe la Francaise trimmed its stake in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 10.7% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,889 shares of the medical research company’s stock after selling 4,180 shares during the quarter. Groupe la Francaise’s holdings in Agilent Technologies were worth $4,634,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the stock. Core Wealth Advisors LLC acquired a new stake in Agilent Technologies in the 4th quarter valued at about $26,000. SHP Wealth Management acquired a new position in shares of Agilent Technologies during the fourth quarter worth about $26,000. Navalign LLC purchased a new stake in shares of Agilent Technologies during the fourth quarter worth approximately $27,000. Cedar Mountain Advisors LLC purchased a new stake in shares of Agilent Technologies during the first quarter worth approximately $27,000. Finally, Markowski Investments acquired a new stake in Agilent Technologies in the second quarter valued at approximately $27,000.

Agilent Technologies Trading Down 0.2%

NYSE A opened at $150.60 on Tuesday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05. The firm has a market cap of $42.46 billion, a PE ratio of 29.65, a P/E/G ratio of 2.30 and a beta of 1.24. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $163.75. The firm’s fifty day moving average is $142.62 and its two-hundred day moving average is $128.08.

Agilent Technologies (NYSE:A – Get Free Report) last announced its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.13. The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The business’s quarterly revenue was up 8.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Analysts expect that Agilent Technologies, Inc. will post 6.2 earnings per share for the current year.

Analyst Upgrades and Downgrades

A has been the subject of a number of recent research reports. Sanford C. Bernstein lifted their price target on shares of Agilent Technologies from $155.00 to $180.00 and gave the stock an “outperform” rating in a research note on Thursday, August 27th. Wolfe Research reissued a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. TD Cowen raised their price objective on shares of Agilent Technologies from $155.00 to $180.00 and gave the company a “buy” rating in a report on Thursday, August 27th. HSBC decreased their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Finally, Citigroup boosted their target price on shares of Agilent Technologies from $185.00 to $190.00 and gave the stock a “buy” rating in a research note on Thursday, August 27th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $170.33.

Get Our Latest Research Report on Agilent Technologies

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.